Activated protein C resistance: Difference between revisions

Jump to navigation Jump to search
No edit summary
 
m (Bot: Automated text replacement (-{{SIB}} + & -{{EH}} + & -{{EJ}} + & -{{Editor Help}} + & -{{Editor Join}} +))
Line 2: Line 2:
{{CMG}}
{{CMG}}


{{EH}}
 


==Overview==
==Overview==
Line 23: Line 23:
* {{OMIM|188055}}
* {{OMIM|188055}}


{{SIB}}
 


[[Category:Hematology]]
[[Category:Hematology]]

Revision as of 20:40, 8 August 2012

WikiDoc Resources for Activated protein C resistance

Articles

Most recent articles on Activated protein C resistance

Most cited articles on Activated protein C resistance

Review articles on Activated protein C resistance

Articles on Activated protein C resistance in N Eng J Med, Lancet, BMJ

Media

Powerpoint slides on Activated protein C resistance

Images of Activated protein C resistance

Photos of Activated protein C resistance

Podcasts & MP3s on Activated protein C resistance

Videos on Activated protein C resistance

Evidence Based Medicine

Cochrane Collaboration on Activated protein C resistance

Bandolier on Activated protein C resistance

TRIP on Activated protein C resistance

Clinical Trials

Ongoing Trials on Activated protein C resistance at Clinical Trials.gov

Trial results on Activated protein C resistance

Clinical Trials on Activated protein C resistance at Google

Guidelines / Policies / Govt

US National Guidelines Clearinghouse on Activated protein C resistance

NICE Guidance on Activated protein C resistance

NHS PRODIGY Guidance

FDA on Activated protein C resistance

CDC on Activated protein C resistance

Books

Books on Activated protein C resistance

News

Activated protein C resistance in the news

Be alerted to news on Activated protein C resistance

News trends on Activated protein C resistance

Commentary

Blogs on Activated protein C resistance

Definitions

Definitions of Activated protein C resistance

Patient Resources / Community

Patient resources on Activated protein C resistance

Discussion groups on Activated protein C resistance

Patient Handouts on Activated protein C resistance

Directions to Hospitals Treating Activated protein C resistance

Risk calculators and risk factors for Activated protein C resistance

Healthcare Provider Resources

Symptoms of Activated protein C resistance

Causes & Risk Factors for Activated protein C resistance

Diagnostic studies for Activated protein C resistance

Treatment of Activated protein C resistance

Continuing Medical Education (CME)

CME Programs on Activated protein C resistance

International

Activated protein C resistance en Espanol

Activated protein C resistance en Francais

Business

Activated protein C resistance in the Marketplace

Patents on Activated protein C resistance

Experimental / Informatics

List of terms related to Activated protein C resistance

Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]


Overview

Activated protein C resistance is a hemostatic disorder characterized by a poor anticoagulant response to activated protein C (APC). This results in an increased risk of venous thrombosis.

Activated protein C (with protein S as a cofactor) degrades Factor Va and Factor VIIIa. Activated protein C resistance is the inability of protein C to cleave Factor Va and/or Factor VIIIa, which allows for longer duration of thrombin generation and may lead to a hypercoagulable state. This may be hereditary or acquired. The best known and most common hereditary form is Factor V Leiden. Acquired forms occur in the presence of elevated Factor VIII concentrations.

It has been estimated that up to 64% of patients with venous thromboembolism might have activated protein C resistance.

Figure: The Protein C Anticoagulant Pathway: Thrombin escaping from a site of vascular injury binds to its receptor thrombomodulin (TM) on the intact cell surface. As a result, thrombin loses its procoagulant properties and instead becomes a potent activator of protein C. Activated protein C (APC) functions as a circulating anticoagulant, which specifically degrades and inactivates the phospholipid-bound factors Va and VIIIa. This effectively down-regulates the coagulation cascade and limits clot formation to sites of vascular injury. T = Thrombin, PC= Protein C, Activated Protein C= APC, PS= Protein S

References

  • Nicolaes GA, Dahlback B (2003). "Congenital and acquired activated protein C resistance". Semin Vasc Med. 3 (1): 33–46. PMID 15199491
  • Dahlback B (2003). "The discovery of activated protein C resistance". J Thromb Haemost. 1 (1): 3–9. PMID 12871530
  • Sheppard DR (2000). "Activated protein C resistance: the most common risk factor for venous thromboembolism". J Am Board Fam Pract. 13 (2): 111–5. PMID 10764192

External links


Template:WikiDoc Sources